Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108

Summary

The study looks at the safety and blood levels of the study drug INV-347 in participants who were previously dosed with INV-347 in study INV-CL-108. Participants will not get any study drug in this study as it looks into the safety of a drug previously dosed. The study will last until visit 21.

Timeline

Start

2025-08-06

Primary completion

2027-09-15

Completion

2027-09-15

Drugs

Indications